These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 28393653

  • 21. High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus.
    Orjuela A, Suwanichkul A, Canter D, Minard CG, Devaraj S, Hicks MJ, Muscal E, Wenderfer SE.
    Am J Nephrol; 2015; 41(3):241-7. PubMed ID: 25926050
    [Abstract] [Full Text] [Related]

  • 22. The serum levels of connective tissue growth factor in patients with systemic lupus erythematosus and lupus nephritis.
    Wang FM, Yu F, Tan Y, Liu G, Zhao MH.
    Lupus; 2014 Jun; 23(7):655-64. PubMed ID: 24536044
    [Abstract] [Full Text] [Related]

  • 23. Association between the presence of anti-C1q antibodies and active nephritis in patients with systemic lupus erythematosus.
    Gargiulo Mde L, Gómez G, Khoury M, Collado MV, Suárez L, Álvarez C, Sarano J.
    Medicina (B Aires); 2015 Jun; 75(1):23-8. PubMed ID: 25637896
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
    Ezzat M, El-Gammasy T, Shaheen K, Shokr E.
    Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
    [Abstract] [Full Text] [Related]

  • 28. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
    [Abstract] [Full Text] [Related]

  • 29. Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.
    Wirestam L, Enocsson H, Skogh T, Eloranta ML, Rönnblom L, Sjöwall C, Wetterö J.
    Clin Exp Immunol; 2017 Jul; 189(1):83-91. PubMed ID: 28257596
    [Abstract] [Full Text] [Related]

  • 30. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures.
    Wakasugi D, Gono T, Kawaguchi Y, Hara M, Koseki Y, Katsumata Y, Hanaoka M, Yamanaka H.
    J Rheumatol; 2012 Jan; 39(1):79-85. PubMed ID: 22089455
    [Abstract] [Full Text] [Related]

  • 31. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [Abstract] [Full Text] [Related]

  • 32. Vaccination of mice for research purpose: alum is as effective as and safer than complete Freund adjuvant.
    Bassi N, Luisetto R, Ghirardello A, Gatto M, Bottazzi B, Shoenfeld Y, Punzi L, Doria A.
    Reumatismo; 2012 Dec 20; 64(6):380-7. PubMed ID: 23285482
    [Abstract] [Full Text] [Related]

  • 33. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
    Tripathy R, Panda AK, Das BK.
    Lupus; 2015 Jan 20; 24(1):82-9. PubMed ID: 25253568
    [Abstract] [Full Text] [Related]

  • 34. Co-Positivity for Anti-dsDNA, -Nucleosome and -Histone Antibodies in Lupus Nephritis Is Indicative of High Serum Levels and Severe Nephropathy.
    Yang J, Xu Z, Sui M, Han J, Sun L, Jia X, Zhang H, Han C, Jin X, Gao F, Liu Y, Li Y, Cao J, Ling H, Zhang F, Ren H.
    PLoS One; 2015 Jan 20; 10(10):e0140441. PubMed ID: 26465327
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Frémeaux-Bacchi V, Martinez-Ara J, Jancova E, Picazo ML, Honsova E, Tesar V, Sadallah S, Schifferli J.
    Nephrol Dial Transplant; 2006 Nov 20; 21(11):3115-21. PubMed ID: 16877491
    [Abstract] [Full Text] [Related]

  • 38. Serum and Urinary Interferon-Gamma-Inducible Protein 10 in Lupus Nephritis.
    El-Gohary A, Hegazy A, Abbas M, Kamel N, Nasef SI.
    J Clin Lab Anal; 2016 Nov 20; 30(6):1135-1138. PubMed ID: 27184880
    [Abstract] [Full Text] [Related]

  • 39. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
    Mak A, Cheung BM, Mok CC, Leung R, Lau CS.
    Rheumatology (Oxford); 2006 Oct 20; 45(10):1266-72. PubMed ID: 16595522
    [Abstract] [Full Text] [Related]

  • 40. Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up.
    Pesickova SS, Rysava R, Lenicek M, Vitek L, Potlukova E, Hruskova Z, Jancova E, Honsova E, Zavada J, Trendelenburg M, Tesar V.
    Arthritis Res Ther; 2015 Dec 24; 17():371. PubMed ID: 26704903
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.